CV Health: Risk Prevention, Challenges, Education

Results of a study at the Veterans Health Administration found that feedback and education led to better medication outcomes for patients.

Study results are especially important for women, who are more likely to experience heart failure with mildly reduced or preserved ejection fraction.

A PDUFA date for acoramidis has been set for November 29, 2024.

High copayments can be a structural barrier to medication therapy adherence.

In a comprehensive literature review, researchers addressed the impact cardiac surgery has on gastrointestinal outcomes.

Pharmacists can screen for social determinants of health and patient beliefs about medications as a way to improve adherence and subsequent outcomes in heart failure.